CIK 0001156039 · Large accelerated filer
Elevance Health, Inc.
Sign in to watch- Ticker
- ELV
- Exchange
- NYSE
- Industry
- Hospital & Medical Service Plans
- FY end
- Dec 31
- Incorporated
- IN
- Entity type
- operating
- EIN
- 352145715
- Phone
- 8003311476
- Business address
- 220 VIRGINIA AVENUE, INDIANAPOLIS, IN, 46204
- Former names
- Anthem, Inc., WELLPOINT, INC, WELLPOINT INC, ANTHEM INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $5,230,357
- in 2 filings
Net −$5,230,357. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2024-03-01 | BOUDREAUX GAIL President and CEO | Grant or award | +8,415 | 126,192 | ||
| 2024-03-01 | BOUDREAUX GAIL President and CEO | Grant or award | +34,517 | 160,709 | ||
| 2024-03-01 | BOUDREAUX GAIL President and CEO | Grant or award · Employee Stock Option (Right to Buy) | +32,480 | 32,480 | ||
| 2024-02-07 | PERU RAMIRO G Director | Sale 10b5-1 | −753 | $500.00 | $377K | 9,109 |
| 2024-01-03 | Todt Blair Williams EVP, CLO & CAO | Shares withheld for taxes | −397 | $480.49 | $191K | 12,115 |
| 2023-12-14 | Todt Blair Williams EVP, CLO & CAO | Option exercise | +5,492 | $311.48 | $1.7M | 18,004 |
| 2023-12-14 | Todt Blair Williams EVP, CLO & CAO | Sale | −5,492 | $484.02 | $2.7M | 12,512 |
| 2023-12-14 | Todt Blair Williams EVP, CLO & CAO | Option exercise · Employee Stock Option (Right to Buy) | −5,492 | 2,746 | ||
| 2023-12-01 | Todt Blair Williams EVP, CLO & CAO | Shares withheld for taxes | −1,127 | $483.12 | $544K | 16,029 |
| 2023-12-01 | Todt Blair Williams EVP, CLO & CAO | Shares withheld for taxes | −116 | $483.12 | $56K | 12,512 |
| 2023-11-30 | Penczek Ronald W CAO & Controller | Sale | −1,055 | $475.17 | $501K | 1,787 |
| 2023-11-01 | Haytaian Peter D EVP & Pres Carelon & CarelonRx | Shares withheld for taxes | −154 | $446.66 | $69K | 17,739 |
| 2023-11-01 | Kendrick Charles Morgan JR EVP & President, Commercial | Shares withheld for taxes | −79 | $446.66 | $35K | 15,248 |
| 2023-10-24 | Penczek Ronald W CAO & Controller | Sale | −64 | $454.35 | $29K | 2,842 |
| 2023-10-02 | Kaye Mark EVP & CFO Designate | Grant or award | +18,174 | 18,174 | ||
| 2023-10-02 | Kaye Mark EVP & CFO Designate | Grant or award | +2,102 | 20,276 | ||
| 2023-10-02 | Kaye Mark EVP & CFO Designate | Grant or award · Employee Stock Option (Right to Buy) | +8,076 | 8,076 | ||
| 2023-07-21 | Dixon Robert L JR Director | Sale | −310 | $476.71 | $148K | 9,638 |
| 2023-05-10 | PERU RAMIRO G Director | Grant or award | +457 | 9,862 | ||
| 2023-05-10 | HAY LEWIS III Director | Grant or award | +457 | 10,518 |
Page 11 of 26 · 514 trades